Response of patients and chest x-ray improvement after Remdesivir
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/029266
- Lead Sponsor
- Vishal Shanbhag
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients aged 18-90 years were included
Patients who have been proven COVID-19 positive by reverse transcriptase polymerase chain reaction (RT-PCR),and the rapid antigen test.
COVID -19 patients admitted between June 2020 and September 2020
Patients above 18 years admitted to hospital or critical care unit and on oxygen therapy, non-invasive ventilation (NIV) or invasive mechanical ventilation (IMV)
Patients with pre-existing liver disorders.
2. Patients with any prior hypoalbuminemic state.
3. Patients with hematological malignancies, immunocompromised states.
4. Patients with fluid resuscitations where the serum albumin level couldbe altered.
5. patients with trauma,extensive bowel resection,burns
6. Patients with AKI or CKD with possible albumin loss in urine
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of CAR, NAR, CXR score after administration of remdesivir. SpO2, PaO2, FiO2, Pao2/Fio2 will be evaluated.Timepoint: Correlation of CAR, NAR, CXR score,at baseline and after 48hrs,72hrs,5days post administration of remdesivir. SpO2, PaO2, FiO2, Pao2/Fio2 will be evaluated at baseline and 48hrs,72hrs,5 days post administration of remdesivir
- Secondary Outcome Measures
Name Time Method Days of hospital admission, outcome of hospital or ICU stay.Timepoint: 28 days after ICU admission